Effectiveness and Response Predictors of Omalizumab in Treating Patients with Seasonal Allergic Rhinitis: A Real-World Study

BACKGROUND: Omalizumab has been proven effective and safety in treating seasonal allergic rhinitis (SAR) by several randomized clinical trials in many countries. However, there is lack of clinical reports of Chinese patients with SAR treated by omalizumab. OBJECTIVE: In the present real-world-design...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Tingting, Wang, Hongtian, Wang, Xueyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837594/
https://www.ncbi.nlm.nih.gov/pubmed/33519214
http://dx.doi.org/10.2147/JAA.S288952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837594/
https://www.ncbi.nlm.nih.gov/pubmed/33519214
http://dx.doi.org/10.2147/JAA.S288952

Ejemplares similares